Skip to content

Novotergum is a German healthcare provider operating more than 70 physiotherapy, occupational therapy and speech therapy centres across Germany.

Last updated September 29, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Novotergum is a German healthcare company headquartered in Essen that operates a nationwide network of therapy centres. Its core business is the development, establishment and operation of physiotherapy services, complemented by occupational therapy (Ergotherapie) and speech therapy (Logopädie). According to its official website, the company runs more than 70 locations across Germany and employs over 850 staff, and it states that it is a leading provider of physiotherapy, occupational therapy and speech therapy in the country. The company emphasises high quality standards, evidenced by numerous TÜV certifications, and describes an ambition to rethink healthcare delivery and raise the standing of remedial therapies. Novotergum is recognised by all statutory health insurance companies in Germany (Kassenzulassung), meaning its services are reimbursable for patients covered by the statutory system. Its clinical focus lies in orthopaedic-traumatological and neurological rehabilitation. The company positions itself around quality, innovation and a patient-oriented philosophy, and it also promotes itself as an employer, recruiting therapists and support staff for its centre network. The business traces its origins to 1999, when the first centre was founded in Bochum under the name Zentrum für Gesundheitsförderung GmbH. The founding managing director and majority shareholder was Christian Barth, a graduate in sports science. The company received statutory health insurance accreditation in 2002 and was renamed Novotergum Holding AG in 2004. In 2012 the holding filed for insolvency; 18 of 56 physiotherapy centres were closed and the entity was reorganised as Novotergum AG, split into NT-Nord GmbH and NT-Süd GmbH. Today the company operates as NOVOTERGUM GmbH with headquarters in Essen and continues to expand its network of therapy centres. Beyond direct patient care, Novotergum maintains a knowledge platform on its website covering topics such as joint pain in cold weather, structured programmes for knee and hip osteoarthritis (GLA:D® Germany), blank prescriptions for shoulder therapy, and medical exercise therapy for oncology patients. This content marketing supports its positioning as a quality-oriented therapy provider and helps attract both patients and employees.

History

Novotergum's history began in 1999, when the first centre was founded in Bochum under the name Zentrum für Gesundheitsförderung GmbH. The company was established as a GmbH, and the majority shareholder and first managing director was Christian Barth, a graduate in sports science (Diplom-Sportwissenschaftler). The initial focus was on developing and operating physiotherapy services. In 2002, the company received accreditation from statutory health insurance companies (Kassenzulassung), a key milestone that allowed its services to be reimbursed for patients covered by the statutory system. This accreditation remains central to its business model. In 2004, the company was renamed from Zentrum für Gesundheitsförderung GmbH to Novotergum Holding AG, reflecting its growth and ambition to build a larger network of therapy centres. By 2012, the holding company operated 56 physiotherapy centres. In that year, the holding filed for insolvency. As part of the restructuring, 18 of the 56 existing physiotherapy centres were closed, and the holding was reorganised into Novotergum AG. The new entity was divided into two operating companies, NT-Nord GmbH and NT-Süd GmbH, which together operated 26 physiotherapy centres in North Rhine-Westphalia and Baden-Württemberg. Today, Novotergum operates as NOVOTERGUM GmbH with its registered office in Essen. According to its official website, the company has grown to more than 70 locations across Germany and employs over 850 staff. It describes itself as a leading provider of physiotherapy, occupational therapy and speech therapy in Germany, with numerous TÜV certifications underlining its quality standards. The company continues to pursue a strategy of quality, innovation and patient-oriented care, and it maintains an active content platform discussing therapy topics such as osteoarthritis, back pain and rehabilitation programmes.

  • 2012

    Holding files for insolvency; 18 of 56 physiotherapy centres closed; reorganised as Novotergum AG, split into NT-Nord GmbH and NT-Süd GmbH operating 26 centres.

  • 2004

    Renamed from Zentrum für Gesundheitsförderung GmbH to Novotergum Holding AG.

  • 2002

    Company receives accreditation from statutory health insurance companies (Kassenzulassung).

  • 1999

    First Novotergum centre founded in Bochum as Zentrum für Gesundheitsförderung GmbH; Christian Barth becomes majority shareholder and first managing director.

  • Company operates as NOVOTERGUM GmbH with headquarters in Essen, more than 70 locations and over 850 employees.

Products and positioning

Leading German provider of physiotherapy, occupational therapy and speech therapy, emphasising quality (TÜV-certified), innovation and patient-oriented care.

  • Physiotherapy

    Core service; orthopaedic-traumatological and neurological rehabilitation.

  • Occupational therapy (Ergotherapie)

    Support for everyday life activities.

  • Speech therapy (Logopädie)

    Therapy for clear and distinct speech.

  • Medical exercise therapy (KGG)

    Including for oncology patients.

  • GLA:D® Germany programme

    Structured programme for knee and hip osteoarthritis.

Sources3 sources

Cite this profile: Cite the canonical profile. /brand-wiki/novotergum · Editorial policy · How profiles are compiled